BRAF and neoplasm: Interestingly, while BRAF/MEKi or anti-PD-1 antibody alone had minimal effect on tumor volume compared with vehicle, combined BRAF/MEK/PD-1 inhibition produced a more substantial and sustained reduction in tumor growth (Fig. 1c and Extended Data Fig. 1d).